Kobayashi Pharmaceutical reported the problem to an outside director about the issue of people who ingested health foods containing Kobayashi Pharmaceutical's red yeast rice and developed kidney disease after learning of the first case. I found out through an interview with the company that it was the day of the press conference, which was just over a month later. The company explained, ``We believe that this was not something that should be reported to outside directors.''
It has been revealed that people who ingested health foods such as Kobayashi Pharmaceutical's Red Yeast Choleste Help, which contains the ingredient Red Yeast, developed kidney disease, resulting in five deaths and a total of 177 hospitalizations. The company is investigating the possibility that this may have been the cause.
It is known that Kobayashi Pharmaceutical received a report of the first case from a doctor on January 15th of this year, and it took more than two months for it to publicize the problem and begin the voluntary recall. In an interview with the company, it was learned that the report was made to the directors on March 22nd, the same day the announcement was made at the press conference.
Kobayashi Pharmaceutical's Board of Directors is made up of seven members, four of whom are outside directors who provide opinions from an outside perspective, but the company also discusses responses with other directors, including the president, and internal executives, including executive officers. That is to say.
Regarding this, Kobayashi Pharmaceutical explains, ``We believe that this was not something that should be reported to outside directors.''